Navigation Links
Canadian Patent Issued to Medizone International for AsepticSure™ Disinfection Technology

SAN FRANCISCO, Nov. 29, 2011 /PRNewswire/ -- Medizone International, Inc. (MZEI:OB MZEI:QB) reports that the Canadian Patent Office has granted Canadian Patent No 2735739 for processes and systems relating to the platform technology of its revolutionary AsepticSure™ hospital disinfection product.

Medizone's lead patent attorney, Robert Hirons, commented on the significance of this Grant: "This foundational lead patent application, 'Healthcare Facility disinfection Process and System with Oxygen/Ozone Mixture' was formally granted as a patent by the Canadian Intellectual Property Office on November 22, 2011. This gives to Medizone the exclusive right to make, use and sell in Canada, the sterilizing apparatus and the sterilizing process covered by the patent, for the full 20-year patent term. In addition, the Canadian patent grant provides a springboard for accelerated issuance of Medizone's corresponding patent applications, e.g. in the United States, with the U.S. Patent Examiners having the benefit of the results of international searches on the novelty of the invention previously generated by the Canadian Examiners."

CEO Edwin Marshall added, "The granting of our foundational patent by the Canadian authorities is confirmation that our patent strategy is sound and on track. It not only signals the beginning of greatly expanded global patent protection for our peer-reviewed AsepticSure™ technology, but brings us another step closer to taking up the fight against superbugs and HAIs, globally. With six international patent applications in place, the foundation for our 'patent protection fence' has now been firmly established."

For press information on Medizone International, please contact:

Bruce Smeaton, Investor Relations, Medizone International, Inc.

T: 001-415-331-0202


Medizone International, Inc. is engaged in initial production of its modular design AsepticSure™ Decontamination Systems. Decontamination to the sterilization standard of >6 log (99.9999%) is obtainable within hospitals, airlines, cruise ships, long term care facilities, food processing plants, clean room manufacturing facilities, schools and other critical infrastructure. A government variant is being tested for bio-terrorism counter measures for building remediation. This Press Release contains certain forward looking statements that may involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

For more information, visit:


SOURCE Medizone International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Apelon Provides Products and Services to Support Canadian Healthcare Data Standardization
2. Masimo Pronto-7™ Receives Japanese and Canadian Regulatory Clearances
3. VeraLight and Pear Healthcare Solutions Sign Canadian Distribution Agreement for SCOUT DS® Noninvasive Diabetes Screening Device
4. Suneva Medical Announces Canadian Approval of Bellafill™
5. Canadian Pharmacy Intermediarys Top Reasons U.S. Customers Choose Canada Online Pharmacies Revealed by
6. Theramed Secures Exclusive Canadian Distribution Rights for Two Novel Obstetrics Products from Glenveigh
7. IDEV Announces Full Canadian Regulatory Approval for SUPERA VERITAS®
8. Canadian Pharmacy Intermediary Celebrates Milestone
9. Medizone Internationals Mass-Market Sterilization Technology to be Produced by Canadian Medical Device Heavyweights
10. BioDrain Medical, Inc. Is Eligible for Trading on the OTCBB, Notice of Allowance on Canadian Patent Application
11. Streamline Health Solutions Enables Electronic Medical Records System for Leading Canadian Healthcare Provider
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):